BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Pharm Country

  Milestone Scientific Closes a $150,000 Offshore Offering of Common Stock at $1.40 Per Share

  February 1, 2012

   · 

  1 min read
• Biotech Bay

  AnaSpec, Inc. Offers Antibodies Against the Hexa-His and GFP Tags

  February 1, 2012

   · 

  1 min read
• Business

  Ligand Pharmaceuticals Inc. to Report Fourth Quarter Results on February 7

  February 1, 2012

   · 

  1 min read
• Business

  Momenta Pharmaceuticals, Inc. Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2011 Financial Results

  February 1, 2012

   · 

  1 min read
• ResearchPoint Expands its Worldwide CRO Coverage in Canada with Integrated Research Inc.

  February 1, 2012

   · 

  1 min read
• Biotech Beach

  REVA Medical Inc. to Present at CRT and LDDR Scientific Conferences

  February 1, 2012

   · 

  1 min read
• European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan

  February 1, 2012

   · 

  3 min read
• ISPE to Present Conferences Focused on Pharmaceutical Aseptic Processing

  February 1, 2012

   · 

  3 min read
• FDA

  FDA Approves Novartis Corporation’s Gleevec for Expanded Use in Patients With Rare Gastrointestinal Cancer

  February 1, 2012

   · 

  3 min read
• FDA

  Bovie Medical Corporation Receives 510K Clearances to Market Patented J-Plasma™ Technology

  February 1, 2012

   · 

  3 min read